Abstract
BackgroundLymphocyte activation gene 3 (LAG-3) has been considered as the next generation of immune checkpoint and a promising prognostic biomarker of immunotherapy. As with programmed cell death protein-1/programmed death-ligand 1...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have